Lamictal Tablet, Film Coated, Extended Release
Product Images NDC 0173-0761

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Lamictal (NDC 0173-0761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamictal Xr Chemical Structure (Lamictalxr Spl Graphic 01)

Chemical structure diagram of lamotrigine, the active ingredient in LAMICTAL XR. The structure shows a triazine ring with chlorine and amine substituents, reflecting the molecular composition typical for lamotrigine.*

FDA Label Image

Lamictal Xr Figure 1 (Lamictalxr Spl Graphic 02)

A cumulative responder rate graph showing the percentage of patients with equal or greater improvement or worsening, comparing Lamictal XR (lamotrigine) extended-release tablets (N=70) to placebo (N=73). The horizontal axis represents the percent of patients, while the vertical axis shows the responder rate from -100% (worsening) to 100% (improvement). The graph uses a solid line for Lamictal XR and a dashed line for placebo.*

FDA Label Image

Lamictal Xr Figure 2 (Lamictalxr Spl Graphic 03)

A responder rate plot comparing Lamictal XR (lamotrigine extended-release) and placebo in patients. The graph shows responder rate (equal or greater improvement versus worsening) on the vertical axis and percent of patients on the horizontal axis, with two curves representing Lamictal XR (N=116) and placebo (N=120). Lamictal XR demonstrates a higher responder rate across the percentage of patients compared to placebo.*

FDA Label Image

25 mg Tablet (Lamictalxr Spl Graphic 04)

The image shows a white, round, film-coated extended-release tablet of LAMICTAL XR (lamotrigine), a prescription drug by GlaxoSmithKline LLC. The tablet has an imprint of an incomplete circle surrounding the letters "C E" and the number "3" below it, which are visible on one side. No dosage strength is visible in the image.*

FDA Label Image

50 mg Tablet (Lamictalxr Spl Graphic 05)

LAMICTAL XR 100 mg extended-release film-coated tablet. The white oval-shaped tablet is debossed with a circular logo containing an outer ring and a smaller circle inside with a pattern resembling a sun or rays. The imprint includes the code 'XR 86.'*

FDA Label Image

100 mg Tablet (Lamictalxr Spl Graphic 06)

LAMICTAL XR 100 mg extended release film-coated tablet. The round, white tablet is marked with "LAMICTAL XR 100". This oral prescription medication is labeled by GlaxoSmithKline LLC.*

FDA Label Image

200 mg Tablet (Lamictalxr Spl Graphic 07)

FDA Label Image

250 mg Tablet (Lamictalxr Spl Graphic 08)

A white, circular film-coated extended-release tablet labeled LAMICTAL XR containing lamotrigine, with an imprint of 'LAMICTAL XR 250' and a symbol above the text. This tablet corresponds to the 250 mg strength and is manufactured by GlaxoSmithKline LLC.*

FDA Label Image

300 mg Tablet (Lamictalxr Spl Graphic 09)

LAMICTAL XR 300 mg extended release film-coated tablet. The tablet is round, white, and scored, with the imprint 'LAMICTAL XR 300' on one side. Manufactured by GlaxoSmithKline LLC.*

FDA Label Image

Lamictal Xr 25mg 30 Count Label (Lamictalxr Spl Graphic 10)

Packaging label for LAMICTAL XR 25 mg extended-release tablets by GlaxoSmithKline LLC. Includes the proprietary name, generic name lamotrigine, dosage form as oral extended-release tablets, package count of 30 tablets, and a caution to verify product dispensed. Label features barcode, NDC 0173-0754-00, and dosage strength highlighted in yellow.*

FDA Label Image

Lamictal Xr 50mg 30 Count Label (Lamictalxr Spl Graphic 11)

LAMICTAL XR 50 mg extended-release tablets label by GlaxoSmithKline LLC. The label shows a single round pink tablet marked 'LAMICTAL XR 50' and indicates a bottle of 30 tablets. It includes cautions to verify product dispensed and dispensing instructions, with text emphasizing 'Once A Day' dosing.*

FDA Label Image

Lamictal Xr 100 mg 30 Count Label (Lamictalxr Spl Graphic 12)

Packaging label for LAMICTAL XR 100 mg extended-release tablets by GlaxoSmithKline LLC. The label features the product name with strength and dosage form, a sample tablet image marked 'LAMICTAL XR 100,' and states '30 tablets' per package. It includes usage cautions, storage instructions, and regulatory information.*

FDA Label Image

Lamictal Xr 200mg 30 Count Label (Lamictalxr Spl Graphic 13)

Label for LAMICTAL XR (lamotrigine) extended-release tablets, 200 mg strength, oral dosage form, film-coated tablets. The label indicates a package containing 30 tablets, includes caution to verify the product dispensed, and states to dispense the accompanying medication guide. Manufactured by GlaxoSmithKline LLC. The label shows the product is Rx only and includes storage instructions and a barcode.*

FDA Label Image

Lamictal Xr 250mg 30 Count Label (Lamictalxr Spl Graphic 14)

LAMICTAL XR 250 mg extended-release tablets hard blister pack label showing one pink, oval tablet with imprint. The label states it is for once a day use and includes 30 tablets per pack. The manufacturer is GlaxoSmithKline LLC.*

FDA Label Image

Lamictal Xr 300mg 30 Count Label (Lamictalxr Spl Graphic 15)

LAMICTAL XR 300 mg extended-release film-coated tablets bottle label by GlaxoSmithKline LLC. The label indicates 30 tablets per bottle, with instructions to verify the product dispensed and to provide the accompanying medication guide. The label also includes storage and handling information, a barcode, and the Rx only designation.*

FDA Label Image

Lamictal Xr Kit 21 Count 25mg 7 Count 50mg Card (Lamictalxr Spl Graphic 16)

LAMICTAL XR (lamotrigine) extended-release tablets packaging label from GlaxoSmithKline LLC. The label highlights a patient titration kit containing 21 tablets of 25 mg and 7 tablets of 50 mg lamotrigine. Instructions for dosing over 5 weeks are included, with emphasis on use for patients taking valproate. The label also advises consultation with a physician about proper maintenance dosing and includes a caution to verify the product dispensed.*

FDA Label Image

Lamictal Xr Kit 14 Count 50mg 14 Count 100mg 7 Count 200mg Card (Lamictalxr Spl Graphic 17)

Packaging label for LAMICTAL XR (lamotrigine) extended-release tablets by GlaxoSmithKline LLC. The label highlights a patient titration kit including 14 tablets of 50 mg, 14 tablets of 100 mg, and 7 tablets of 200 mg dosage strengths. Tablets are film-coated, oral, extended release, with instructions for dosing over five weeks. The label includes warnings about drug interactions and dispensing guidelines.*

FDA Label Image

Lamictal Xr Kit 14 Count 25mg 14 Count 50mg 7 Count 100mg Card (Lamictalxr Spl Graphic 18)

Packaging label for LAMICTAL XR (lamotrigine) extended-release tablets by GlaxoSmithKline LLC. The label shows the product name prominently with strength information for 25 mg, 50 mg, and 100 mg tablets included in a patient titration kit. It details tablet count for each strength and dosage instructions across weeks 1 to 5, advising consultation with a physician and caution to verify the dispensed product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.